-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
POINT Biopharma Global Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2023.
- POINT Biopharma Global Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$24.8M, a 3.17% decline year-over-year.
- POINT Biopharma Global Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was $96.6M.
- POINT Biopharma Global Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $98.3M.
- POINT Biopharma Global Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$45.9M, a 243% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)